The serine/threonine protein kinase c-Raf-1 interacts with a number of
cellular proteins including 14-3-3 isoforms which may be regulators o
r substrates of c-Raf-1 in signal transduction pathways, In vivo and i
n vitro binding analyses of c-Raf-1 and mutant proteins with 14-3-3 ze
ta indicate bivalent binding of 14-3-3 zeta to the amino terminus as w
ell as to the carboxy terminus of c-Raf-1, Although 14-3-3 zeta and Ra
s use different binding regions on the amino terminal regulatory domai
n of c-Raf-1 (c-Raf-NT), 14-3-3 zeta is displaced from the amino termi
nus upon binding of activated Ras, In contrast, if c-Raf-1 full length
is analysed instead of the separately expressed c-Raf-NT, binding of
14-3-3 zeta is only slightly effected by co-expression of activated Ra
s, This is explained by a second binding site of 14-3-3 zeta at the ca
rboxy terminus of c-Raf-1. The mutant c-Raf-NT (S259A) cannot bind 14-
3-3 zeta, suggesting a regulatory role of this in vivo phosphorylation
site, However, c-Raf-NT phosphorylated or unphosphorylated at S259, i
s able to bind 14-3-3 zeta, Even though 14-3-3 zeta can be phosphoryla
ted in vivo, only the unphosphorylated form binds to the amino terminu
s of c-Raf-1, The data presented indicate, that 14-3-3 zeta binds to c
-Raf-1 in a bivalent fashion in unstimulated cells, 14-3-3 zeta is dis
placed from the amino terminus but not from the carboxy terminus of c-
Raf-1 by binding of activated Ras to c-Raf-1.